Hematopoietic stem cell transplantation in Niemann–Pick disease type B monitored by chitotriosidase activity

Abstract

Here, we report a patient with Niemann–Pick disease type B, with early severe onset of disease and pulmonary involvement, treated with hematopoietic stem cell transplant (HSCT) from a bone marrow matched unrelated donor. We confirm that HSCT is feasible and potentially beneficial for patients with severe phenotype. Noteworthy, we discussed the potential usefulness of the activity of peripheral chitotriosidase for the longitudinal evaluation of HSCT success and effectiveness.

from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2htjn4d